~10 spots leftby Jul 2026

TMS for Speech

Recruiting in Palo Alto (17 mi)
Overseen byCarrie Niziolek, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Wisconsin, Madison
No Placebo Group
Approved in 3 Jurisdictions

Trial Summary

What is the purpose of this trial?The purpose of this research study is to understand how the brain processes and controls speech in healthy people. The investigators are doing this research because it will help identify the mechanisms that allow people to perceive their own speech errors and to learn new speech sounds, which may be applied to people who have communication disorders. 15 participants will be enrolled into this part of the study and can expect to be on study for 4 visits of 2-4 hours each.

Eligibility Criteria

This trial is for healthy individuals interested in how the brain controls speech. Participants should be available for 4 visits, each lasting 2-4 hours. The eligibility criteria are not fully listed here, so potential participants would need to contact the researchers for more details.

Inclusion Criteria

I am an adult who speaks English.
I have never had a stroke or neurological conditions.
I can hear and speak normally.

Exclusion Criteria

My family has a history of epilepsy.
Vulnerable populations (minors and prisoners)
Implanted paramagnetic materials (metal clips, plates, pacemakers, etc.)
+15 more

Participant Groups

The study is testing the effects of Transcranial Magnetic Stimulation (TMS) on speech processing and control during speaking tasks. It aims to understand how people perceive their own speech errors and learn new sounds.
1Treatment groups
Experimental Treatment
Group I: Healthy Adult SpeakersExperimental Treatment2 Interventions
healthy adult participants across the lifespan in three groups:18-35, 36-55, and 56+

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
University of WisconsinMadison, WI
Loading ...

Who Is Running the Clinical Trial?

University of Wisconsin, MadisonLead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)Collaborator

References